POLITICSSCMP CHINA
Senate bill seeks to curb US reliance on China in drug industry
US lawmakers are pushing for increased scrutiny of Chinese investment in pharmaceuticals and biotechnology. A bipartisan Senate bill aims to enhance transparency in foreign influence within the pharmaceutical industry, driven by concerns over US dependence on China for critical drug ingredients and medical supply chains.
Mentioned
Related Signal
Adjacent reporting
- US must act quickly to counter China’s growing tech progress, lawmakers told
- STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more
- U.S. senators seek to block foreign adversaries from AI technology in new bill
- Lawmakers seek to counter China, Iran repression tactics on US soil